The Retrospective Study of Second‐line Chemotherapy in Ovarian Cancer
Identifieur interne : 000B80 ( Main/Exploration ); précédent : 000B79; suivant : 000B81The Retrospective Study of Second‐line Chemotherapy in Ovarian Cancer
Auteurs : Hiroshi Nishii [Japon] ; Makoto Yasuda [Japon] ; Toshiki Wachi [Japon] ; Eizo Kimura [Japon] ; Kazuhiko Ochiai [Japon] ; Kazunori Ochiai [Japon] ; Tadao Tanaka [Japon]Source :
- Journal of Obstetrics and Gynaecology Research [ 1341-8076 ] ; 2003-02.
English descriptors
- Teeft :
- Acta, Acta obst gynaec, Acta obstetrica, Blackwell science, Chemotherapy, Cumulative survival rate, Eizo, Eizo kimura, Epitherial, February, Gynaec, Gynaecol, Gynaecologica, Gynaecologica japonica, Gynaecology, Gynaecology asia, Gynecology, Hiroshi, Hiroshi nishii, Histological, Histological diagnosis, Japan objective, Japonica, Jikei, Jikei university school, Jogthe, Jogthe journal, Kaplanmeier, Kaplanmeier method, Kazuhiko, Kazuhiko ochiai, Kazunori, Kazunori ochiai, Kimura, Laparotomy, Line chemotherapy, Ltdoxford, Makoto, Makoto yasuda, Median survival time, Negative group months, Nishii, Obst, Obstet, Obstetrica, Obstetrics, Oceania federation, Ochiai, Ovarian, Ovarian cancer, Ovarian cancer hiroshi nishii, Paclitaxel, Positive group months, Retrospective study, Retrospectively, Second line chemotherapy, Sgml, Short term, Survival period, Survival rate, Survival rates, Tadao, Tadao tanaka department, Tanaka, Tokyo japan, Toshiki, Toshiki wachi, Wachi, Yasuda.
Abstract
Objective: To evaluate the efficacy of Second‐line Chemotherapy for ovarian cancer not from short term efficacy but from the survival rate.
Patients and Methods: Eighty‐seven patients with epitherial ovarian cancer treated with Second‐line chemotherapy from 1993 were examined retrospectively. All the patients were treated with platinum as first line chemotherapy (≥ 3 courses). Paclitaxel was used for Second‐line Chemotherapy in 25 patients. The Kaplan‐Meier Method and Log‐Rank Test were carried out for the cumulative survival rate and analysis.
Results: The Median Survival Time of all patients after Second‐line Chemotherapy was 23.6 months. Any significant difference in the survival rate was recognized only by the histological diagnosis (p < 0.0001). There was no significant difference in the survival rates whether patients were treated with paclitaxel as second line chemotherapy or not (p = 0.1915). The disease free survival period of the Second Look Laparotomy (SLL) negative group (23.9 months) is longer than that of SLL positive group (6.2 months).
Conclusions: The survival rate after Second‐line Chemotherapy was influenced only by histological diagnosis.
ACTA OBST GYNAEC JPN Vol. 54, No. 9, pp. 1429–1436, 2002
Url:
DOI: 10.1046/j.1341-8076.2003.00075.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001361
- to stream Istex, to step Curation: 000F48
- to stream Istex, to step Checkpoint: 000A95
- to stream Main, to step Merge: 000B97
- to stream Main, to step Curation: 000B80
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Retrospective Study of Second‐line Chemotherapy in Ovarian Cancer</title><author><name sortKey="Nishii, Hiroshi" sort="Nishii, Hiroshi" uniqKey="Nishii H" first="Hiroshi" last="Nishii">Hiroshi Nishii</name></author><author><name sortKey="Yasuda, Makoto" sort="Yasuda, Makoto" uniqKey="Yasuda M" first="Makoto" last="Yasuda">Makoto Yasuda</name></author><author><name sortKey="Wachi, Toshiki" sort="Wachi, Toshiki" uniqKey="Wachi T" first="Toshiki" last="Wachi">Toshiki Wachi</name></author><author><name sortKey="Kimura, Eizo" sort="Kimura, Eizo" uniqKey="Kimura E" first="Eizo" last="Kimura">Eizo Kimura</name></author><author><name sortKey="Ochiai, Kazuhiko" sort="Ochiai, Kazuhiko" uniqKey="Ochiai K" first="Kazuhiko" last="Ochiai">Kazuhiko Ochiai</name></author><author><name sortKey="Ochiai, Kazunori" sort="Ochiai, Kazunori" uniqKey="Ochiai K" first="Kazunori" last="Ochiai">Kazunori Ochiai</name></author><author><name sortKey="Tanaka, Tadao" sort="Tanaka, Tadao" uniqKey="Tanaka T" first="Tadao" last="Tanaka">Tadao Tanaka</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4A90D06CF483466677FE909F7268AE064CE5AF2E</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1046/j.1341-8076.2003.00075.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-LZ22TSS4-9/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001361</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001361</idno><idno type="wicri:Area/Istex/Curation">000F48</idno><idno type="wicri:Area/Istex/Checkpoint">000A95</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A95</idno><idno type="wicri:doubleKey">1341-8076:2003:Nishii H:the:retrospective:study</idno><idno type="wicri:Area/Main/Merge">000B97</idno><idno type="wicri:Area/Main/Curation">000B80</idno><idno type="wicri:Area/Main/Exploration">000B80</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">The Retrospective Study of Second‐line Chemotherapy in Ovarian Cancer</title><author><name sortKey="Nishii, Hiroshi" sort="Nishii, Hiroshi" uniqKey="Nishii H" first="Hiroshi" last="Nishii">Hiroshi Nishii</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Correspondence address: Reprint request to: Dr Hiroshi Nishii, Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo 125–0034</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Yasuda, Makoto" sort="Yasuda, Makoto" uniqKey="Yasuda M" first="Makoto" last="Yasuda">Makoto Yasuda</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Wachi, Toshiki" sort="Wachi, Toshiki" uniqKey="Wachi T" first="Toshiki" last="Wachi">Toshiki Wachi</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Kimura, Eizo" sort="Kimura, Eizo" uniqKey="Kimura E" first="Eizo" last="Kimura">Eizo Kimura</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Ochiai, Kazuhiko" sort="Ochiai, Kazuhiko" uniqKey="Ochiai K" first="Kazuhiko" last="Ochiai">Kazuhiko Ochiai</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Ochiai, Kazunori" sort="Ochiai, Kazunori" uniqKey="Ochiai K" first="Kazunori" last="Ochiai">Kazunori Ochiai</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Tanaka, Tadao" sort="Tanaka, Tadao" uniqKey="Tanaka T" first="Tadao" last="Tanaka">Tadao Tanaka</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Obstetrics and Gynaecology Research</title><title level="j" type="alt">JOURNAL OF OBSTETRICS GYNAECOLOGY RESEARCH</title><idno type="ISSN">1341-8076</idno><idno type="eISSN">1447-0756</idno><imprint><biblScope unit="vol">29</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="56">56</biblScope><biblScope unit="page" to="56">56</biblScope><biblScope unit="page-count">1</biblScope><publisher>Blackwell Science, Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2003-02">2003-02</date></imprint><idno type="ISSN">1341-8076</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1341-8076</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acta</term><term>Acta obst gynaec</term><term>Acta obstetrica</term><term>Blackwell science</term><term>Chemotherapy</term><term>Cumulative survival rate</term><term>Eizo</term><term>Eizo kimura</term><term>Epitherial</term><term>February</term><term>Gynaec</term><term>Gynaecol</term><term>Gynaecologica</term><term>Gynaecologica japonica</term><term>Gynaecology</term><term>Gynaecology asia</term><term>Gynecology</term><term>Hiroshi</term><term>Hiroshi nishii</term><term>Histological</term><term>Histological diagnosis</term><term>Japan objective</term><term>Japonica</term><term>Jikei</term><term>Jikei university school</term><term>Jogthe</term><term>Jogthe journal</term><term>Kaplanmeier</term><term>Kaplanmeier method</term><term>Kazuhiko</term><term>Kazuhiko ochiai</term><term>Kazunori</term><term>Kazunori ochiai</term><term>Kimura</term><term>Laparotomy</term><term>Line chemotherapy</term><term>Ltdoxford</term><term>Makoto</term><term>Makoto yasuda</term><term>Median survival time</term><term>Negative group months</term><term>Nishii</term><term>Obst</term><term>Obstet</term><term>Obstetrica</term><term>Obstetrics</term><term>Oceania federation</term><term>Ochiai</term><term>Ovarian</term><term>Ovarian cancer</term><term>Ovarian cancer hiroshi nishii</term><term>Paclitaxel</term><term>Positive group months</term><term>Retrospective study</term><term>Retrospectively</term><term>Second line chemotherapy</term><term>Sgml</term><term>Short term</term><term>Survival period</term><term>Survival rate</term><term>Survival rates</term><term>Tadao</term><term>Tadao tanaka department</term><term>Tanaka</term><term>Tokyo japan</term><term>Toshiki</term><term>Toshiki wachi</term><term>Wachi</term><term>Yasuda</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">Objective: To evaluate the efficacy of Second‐line Chemotherapy for ovarian cancer not from short term efficacy but from the survival rate.</div><div type="abstract">Patients and Methods: Eighty‐seven patients with epitherial ovarian cancer treated with Second‐line chemotherapy from 1993 were examined retrospectively. All the patients were treated with platinum as first line chemotherapy (≥ 3 courses). Paclitaxel was used for Second‐line Chemotherapy in 25 patients. The Kaplan‐Meier Method and Log‐Rank Test were carried out for the cumulative survival rate and analysis.</div><div type="abstract">Results: The Median Survival Time of all patients after Second‐line Chemotherapy was 23.6 months. Any significant difference in the survival rate was recognized only by the histological diagnosis (p < 0.0001). There was no significant difference in the survival rates whether patients were treated with paclitaxel as second line chemotherapy or not (p = 0.1915). The disease free survival period of the Second Look Laparotomy (SLL) negative group (23.9 months) is longer than that of SLL positive group (6.2 months).</div><div type="abstract">Conclusions: The survival rate after Second‐line Chemotherapy was influenced only by histological diagnosis.</div><div type="abstract">ACTA OBST GYNAEC JPN Vol. 54, No. 9, pp. 1429–1436, 2002</div></front></TEI><affiliations><list><country><li>Japon</li></country><region><li>Région de Kantō</li></region><settlement><li>Tokyo</li></settlement></list><tree><country name="Japon"><region name="Région de Kantō"><name sortKey="Nishii, Hiroshi" sort="Nishii, Hiroshi" uniqKey="Nishii H" first="Hiroshi" last="Nishii">Hiroshi Nishii</name></region><name sortKey="Kimura, Eizo" sort="Kimura, Eizo" uniqKey="Kimura E" first="Eizo" last="Kimura">Eizo Kimura</name><name sortKey="Nishii, Hiroshi" sort="Nishii, Hiroshi" uniqKey="Nishii H" first="Hiroshi" last="Nishii">Hiroshi Nishii</name><name sortKey="Ochiai, Kazuhiko" sort="Ochiai, Kazuhiko" uniqKey="Ochiai K" first="Kazuhiko" last="Ochiai">Kazuhiko Ochiai</name><name sortKey="Ochiai, Kazunori" sort="Ochiai, Kazunori" uniqKey="Ochiai K" first="Kazunori" last="Ochiai">Kazunori Ochiai</name><name sortKey="Tanaka, Tadao" sort="Tanaka, Tadao" uniqKey="Tanaka T" first="Tadao" last="Tanaka">Tadao Tanaka</name><name sortKey="Wachi, Toshiki" sort="Wachi, Toshiki" uniqKey="Wachi T" first="Toshiki" last="Wachi">Toshiki Wachi</name><name sortKey="Yasuda, Makoto" sort="Yasuda, Makoto" uniqKey="Yasuda M" first="Makoto" last="Yasuda">Makoto Yasuda</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Informatique/explor/SgmlV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B80 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B80 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Informatique
|area= SgmlV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4A90D06CF483466677FE909F7268AE064CE5AF2E
|texte= The Retrospective Study of Second‐line Chemotherapy in Ovarian Cancer
}}
| This area was generated with Dilib version V0.6.33. |  |